|
• May 16. FDA approves new Medication Guide and Label for Varenicline (marketed as Chantix). Drug Information.
• May 16. FDA issues an FDA Alert and Information for Healthcare Professional sheet for Mycophenolate Mofetil (marketed as CellCept) and Mycophenolic Acid (marketed as Myfortic). Drug Information.
• May 14. Manufacturer Removes Remaining Stocks of Trasylol. FDA News and Information.
• May 14. Medtronic Initiates Voluntary Field Actions for Selected Heparin-Coated Products Used During Cardiopulmonary Bypass. Information.
• May 14. FDA releases a Follow-up to the November 14, 2007, Communication about the Ongoing Safety Review of Cefepime (marketed as Maxipime). Information
• May 12. FDA requests that health professionals and facilities review and examine all drug/device storage areas to ensure that all recalled heparin products have been removed and are no longer available for patient use. MedWatch Safety Information
• May 2. The prescribing information for Enbrel (etabercept) is revised to include a boxed warning about infections. MedWatch Safety Information.
Previous News Items |
